The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo
Open accessAbstract
We present evidence that some low-grade oligodendrogliomas may be comprised of proliferating glial progenitor cells that are blocked in their ability to differentiate, whereas malignant gliomas have additionally acquired other mutations such as disruption of cell cycle arrest pathways by loss of Ink4a–Arf.We have modeled these effects in cell culture and in mice by generating autocrine stimulation of glia through the platelet-derived growth factor receptor (PDGFR). In cell culture, PDGF signaling induces proliferation of glial precursors and blocks their differentiation into oligodendrocytes and astrocytes. In addition, coexpression of PDGF and PDGF receptors has been demonstrated in human gliomas, implying that autocrine stimulation may be involved in glioma formation. In this study, using somatic cell type-specific gene transfer we investigated the functions of PDGF autocrine signaling in gliomagenesis by transferring the overexpression of PDGF-B into either nestin-expressing neural progenitors or glial fibrillary acidic protein (GFAP)-expressing astrocytes both in cell culture and in vivo. In cultured astrocytes, overexpression of PDGF-B caused significant increase in proliferation rate of both astrocytes and neural progenitors. Furthermore, PDGF gene transfer converted cultured astrocytes into cells with morphologic and gene expression characteristics of glial precursors. In vivo, gene transfer of PDGF to neural progenitors induced the formation of oligodendrogliomas in about 60% of mice by 12 wk of age; PDGF transfer to astrocytes induced the formation of either oligodendrogliomas or mixed oligoastrocytomas in about 40% of mice in the same time period. Loss of Ink4a–Arf, a mutation frequently found in high-grade human gliomas, resulted in shortened latency and enhanced malignancy of gliomas. The highest percentage of PDGF-induced malignant gliomas arose from of Ink4a–Arf null progenitor cells. These data suggest that chronic autocrine PDGF signaling can promote a proliferating population of glial precursors and is potentially sufficient to induce gliomagenesis. Loss of Ink4a–Arf is not required for PDGF-induced glioma formation but promotes tumor progression toward a more malignant phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Raff, M. C., Miller, R. H., & Noble, M. (1983) · Nature · doi:10.1038/303390a0 · Cited by 2,030
Franke, T. F., Yang, S.-I., Chan, T. O., Datta, K., Kazlauskas, A., Morrison, D. K., Kaplan, D. R., & Tsichlis, P. N. (1995) · Cell · doi:10.1016/0092-8674(95)90534-0 · Cited by 2,006
Cairncross, J. G., Ueki, K., Zlatescu, M. C., Lisle, D. K., Finkelstein, D. M., Hammond, R. R., Silver, J. S., Stark, P. C., Macdonald, D. R., Ino, Y., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.19.1473 · Cited by 1,610
Self-citationSommer, I., & Schachner, M. (1981) · Developmental Biology · doi:10.1016/0012-1606(81)90477-2 · Cited by 1,134
Phenotypes of Mouse diabetes and Rat fatty Due to Mutations in the OB (Leptin) Receptor
Chua, S. C., Chung, W. K., Wu-Peng, X. S., Zhang, Y., Liu, S.-M., Tartaglia, L., & Leibel, R. L. (1996) · Science · doi:10.1126/science.271.5251.994 · Cited by 1,075
Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice
Holland, E. C., Celestino, J., Dai, C., Schaefer, L., Sawaya, R. E., & Fuller, G. N. (2000) · Nature Genetics · doi:10.1038/75596 · Cited by 905
Self-citationStructural alterations of the epidermal growth factor receptor gene in human gliomas.
Wong, A. J., Ruppert, J. M., Bigner, S. H., Grzeschik, C. H., Humphrey, P. A., Bigner, D. S., & Vogelstein, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2965 · Cited by 853
Wong, A. J., Bigner, S. H., Bigner, D. D., Kinzler, K. W., Hamilton, S. R., & Vogelstein, B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6899 · Cited by 849
Wood, J. M., Bold, G., Buchdunger, E., Cozens, R. M., Ferrari, S. M., Frei, J., Hofmann, F., Mestan, J., Mett, H., O'Reilly, T., et al. (2000) · PubMed · Cited by 845
Noble, M., Murray, K., Stroobant, P., Waterfield, M. D., & Riddle, P. (1988) · Nature · doi:10.1038/333560a0 · Cited by 830
A role for platelet-derived growth factor in normal gliogenesis in the central nervous system
Richardson, W. D., Pringle, N., Mosley, M. J., Westermark, B., & Dubois-Dalcg, M. (1988) · Cell · doi:10.1016/0092-8674(88)90392-3 · Cited by 774
Hermanson, M., Funa, N. S., Hartman, M., Claesson, L., Heldin, C., Westermark, B., & Nistér, M. (1992) · PubMed · Cited by 705
REIFENBERGER, J., Reifenberger, G., Liu, L., James, C. D., Wechsler, W., & Collins, V. P. (1994) · PubMed Central · Cited by 601
Holland, E. C., Hively, W. P., DePinho, R. A., & Varmus, H. E. (1998) · Genes & Development · doi:10.1101/gad.12.23.3675 · Cited by 556
Self-citationGliomagenesis: genetic alterations and mouse models
Holland, E. C. (2001) · Nature Reviews Genetics · doi:10.1038/35052535 · Cited by 461
Self-citationIno, Y., Betensky, R. A., Ƶlatescu, M. C., Sasaki, H., Macdonald, D. R., Stemmer-Rachamimov, A. O., Ramsay, D. A., Cairncross, J. G., & Louis, D. N. (2001) · PubMed · Cited by 432
Self-citationClaesson-Welsh, L., Eriksson, A., Westermark, B., & Heldin, C. H. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.13.4917 · Cited by 396
Involvement of p21ras in activation of extracellular signal-regulated kinase 2
de Vries-Smits, A. M. M., Burgering, B. M. T., Leevers, S. J., Mar shall, C. J., & Bos, J. L. (1992) · Nature · doi:10.1038/357602a0 · Cited by 387
Nistér, M., Libermann, T. A., Betsholtz, C., Pettersson, M., Claesson, L., Heldin, C., Schlessinger, J., & Westermark, B. (1988) · PubMed · Cited by 353
Structural Development in Gliomas
Scherer, H.-J. (1938) · American Journal of Cancer · doi:10.1158/ajc.1938.333 · Cited by 314
Bipotential glial precursor cells of the optic nerve express the NG2 proteoglycan
Stallcup, W., & Beasley, L. (1987) · The Journal of Neuroscience · doi:10.1523/jneurosci.07-09-02737.1987 · Cited by 312
Holland, E. C., & Varmus, H. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1218 · Cited by 304
Self-citationMultiple restricted origin of oligodendrocytes
Spassky, N., Goujet-Zalc, C., Parmantier, E., Olivier, C., Martinez, S., Ikenaka, K., Macklin, W., Zalc, B., & Thomas, J.-L. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)91253-x · Cited by 301
Guha, A. R., Dashner, K., Black, P. L. M., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600206 · Cited by 296
Uhrbom, L., Hesselager, G., Nistér, M., & Westermark, B. (1998) · PubMed · Cited by 283
Donehower, L. A., Godley, L. A., Aldaz, C. M., Pyle, R., Shi, Y. P., Pinkel, D., Gray, J., Bradley, A., Medina, D., & Varmus, H. E. (1995) · Genes & Development · doi:10.1101/gad.9.7.882 · Cited by 276
Bigner, S. H., Matthews, M. R., Rasheed, B. K. A., Wiltshire, R. N., Friedman, H. S., Friedman, A. H., Stenzel, T. T., Dawes, D. M., McLendon, R. E., & Bigner, D. D. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65134-6 · Cited by 268
Ichimura, K., Schmidt, E., Goike, H., et al. (1996) · PubMed · Cited by 266
PDGF Mediates a Neuron–Astrocyte Interaction in the Developing Retina
Fruttiger, M., Calver, A. R., Krüger, W. H., Mudhar, H. S., Michalovich, D., Takakura, N., Nishikawa, S. I., & Richardson, W. D. (1996) · Neuron · doi:10.1016/s0896-6273(00)80244-5 · Cited by 258
Hermanson, M., Funa, K., Koopmann, J., Maintz, D. C., Waha, A., Westermark, B., Heldin, C. H., Wiestler, O. D., Louis, D. N., von Deimling, A., et al. (1996) · PubMed · Cited by 255
Self-citationYamaguchi, F., Saya, H., Bruner, J. M., & Morrison, R. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.484 · Cited by 245
PDGF receptors on cells of the oligodendrocyte-type-2 astrocyte (O-2A) cell lineage
Hart, I. K., Richardson, W. D., Heldin, C.-H., Westermark, B., & Raff, M. C. (1989) · Development · doi:10.1242/dev.105.3.595 · Cited by 237
Comparative Study of p53 Gene and Protein Alterations in Human Astrocytic Tumors
Louis, D. N., Deimling, A. V., Chung, R. Y., Rubio, M.-P., Whaley, J. M., Eibl, R. H., Ohgaki, H., Wiestler, O. D., Thor, A. D., & Seizinger, B. R. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199301000-00005 · Cited by 228
Self-citationMutations of the p53 tumor suppressor gene in neoplasms of the human nervous system
Ohgaki, H., Eibl, R. H., Reichel, M. B., Mariani, L., Petersen, I., Höll, T., Wiestler, O. D., Kleihues, P., Schwab, M., & Gehring, M. (1993) · Molecular Carcinogenesis · doi:10.1002/mc.2940080203 · Cited by 226
von Deimling, A., Louis, D. N., von Ammon, K., Petersen, I., Wiestler, O., & Seizinger, B. R. (1992) · PubMed · Cited by 210
Self-citationHall, A., Giese, N. A., & Richardson, W. D. (1996) · Development · doi:10.1242/dev.122.12.4085 · Cited by 209
The Id4 HLH protein and the timing of oligodendrocyte differentiation
Kondo, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.9.1998 · Cited by 203
Shoshan, Y., Nishiyama, A., Chang, A., Mörk, S., Barnett, G. H., Cowell, J. K., Trapp, B. D., & Staugaitis, S. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10361 · Cited by 190
Ransom, D. T., Ritland, S. R., Kimmel, D. W., Moertel, C. A., Dahl, R. J., Scheithauer, B. W., Kelly, P. J., & Jenkins, R. B. (1992) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870050411 · Cited by 180
Trojan, J., Blossey, B. K., Johnson, T. R., Rudin, S. D., Tykocinski, M., Ilan, J., & Ilan, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4874 · Cited by 176
Moriya, S., Kazlauskas, A., Akimoto, K., Hirai, S., Mizuno, K., Takenawa, T., Fukui, Y., Watanabe, Y., Ozaki, S., & Ohno, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.151 · Cited by 167
Josefa Bello, M., Leone, P. E., Vaquero, J., De Campos, J. M., Elena Kusak, M., Sarasa, J. L., Pestaña, A., & Rey, J. A. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640311 · Cited by 160
Weber, R. G., Sabel, M., REIFENBERGER, J., Sommer, C., Oberstraß, J., Reifenberger, G., Kiessling, M., & Cremer, T. J. (1996) · PubMed · Cited by 158
Bertrand, P., Rouillard, D., Boulet, A., Levalois, C., Soussi, T., & López, B. S. (1997) · Oncogene · doi:10.1038/sj.onc.1200931 · Cited by 151
Holland, E. C., Hively, W. P., Gallo, V., & VARMUS, H. E. (1998) · Genes & Development · doi:10.1101/gad.12.23.3644 · Cited by 135
Self-citationCharacterization of a slowly proliferative cell along the oligodendrocyte differentiation pathway.
Dubois-Dalcq, M. E. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02549.x · Cited by 133
Smith, J. S., Wang, X.-Y., Qian, J., Hosek, S. M., Scheithauer, B. W., Jenkins, R. B., & James, C. D. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.6.495 · Cited by 125
Platelet-derived Growth Factor and Its Receptor Expression in Human Oligodendrogliomas
Rocco, F. D., Carroll, R. S., Zhang, J., & Black, P. M. (1998) · Neurosurgery · doi:10.1097/00006123-199802000-00080 · Cited by 123
Williams, B. P., Abney, E. R., & RAFF, M. C. (1985) · Developmental Biology · doi:10.1016/0012-1606(85)90126-5 · Cited by 117
Yahanda, A. M., Bruner, J. M., Donehower, L. A., & Morrison, R. S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4249 · Cited by 97
Holland, E. C., Li, Y., Celestino, J., Dai, C., Schaefer, L., Sawaya, R. A., & Fuller, G. N. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64615-9 · Cited by 81
Self-citationActivation of Hex and mEg5 by retroviral insertion may contribute to mouse B-cell leukemia
Hansen, G. M., & Justice, M. J. (1999) · Oncogene · doi:10.1038/sj.onc.1203023 · Cited by 62
Maier, D., Comparone, D., Taylor, E., Zhang, Z., Gratzl, O., Meir, E. G. V., Scott, R. J., & Merlo, A. U. (1997) · Oncogene · doi:10.1038/sj.onc.1201209 · Cited by 56
Frequency of p53 Tumor Suppressor Gene Mutations in Human Primary Brain Tumors
Wu, J. K., Ye, Z., & Darras, B. T. (1993) · Neurosurgery · doi:10.1227/00006123-199311000-00006 · Cited by 55
Constitutive Expression of Growth-related Oncogene and Its Receptor in Oligodendrogliomas
Robinson, S., Cohen, M. L., Prayson, R. A., Ransohoff, R. M., Tabrizi, N., & Miller, R. H. (2001) · Neurosurgery · doi:10.1097/0006123-200104000-00035 · Cited by 52
Andrés-Barquin, P. J., Hernandez, M., & Israel, M. A. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4360 · Cited by 52
Mouse Molecular Cytogenetic Resource: 157 BACs Link the Chromosomal and Genetic MapsPreprint
Korenberg, J. R., Chen, X.-N., Devon, K. L., Noya, D., Oster‐Granite, M. L., & Birren, B. W. (1999) · Genome Research · doi:10.1101/gr.9.5.514 · Cited by 42
Regulation of Id Gene Expression during Embryonic Stem Cell-Derived Hematopoietic Differentiation
Nogueira, M. M., Mitjavila‐Garcia, M. T., Pesteur, F. L., Filippi, M., Vainchenker, W., Dubart‐Kupperschmitt, A., & Sainteny, F. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3543 · Cited by 27
Louis, D. N., & Cairncross, J. G. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199805000-00027 · Cited by 22
Self-citationDifferentiation-specific mRNA expression of a mouse bipotential glial cell line
Asakura, K., Suzumura, A., Rodriguez, M., & Sawada, M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00862-3 · Cited by 2
Cited by
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
Self-citationRole of platelet-derived growth factors in physiology and medicine
Andrae, J., Gallini, R., & Betsholtz, C. (2008) · Genes & Development · doi:10.1101/gad.1653708 · Cited by 2,438
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., et al. (2007) · Genes & Development · doi:10.1101/gad.1596707 · Cited by 2,316
Self-citationIntegrin signalling during tumour progression
Guo, W., & Giancotti, F. G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1490 · Cited by 1,471
Clement, V., Sanchez, P., de Tribolet, N., Radovanovic, I., & Ruiz i Altaba, A. (2007) · Current Biology · doi:10.1016/j.cub.2006.11.033 · Cited by 1,050
Metadata
- Authors
- Dai, C., Celestino, J. C., Okada, Y., Louis, D. N., Fuller, G. N., & Holland, E. C.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2001-08-01
- Volume
- 15
- Issue
- 15
- Pages
- 1913-1925
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2104917184
- Cited by
- 708
- References
- 61
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.